Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
A software defect that could potentially result in a drop in oxygenation (hypoxia) that is not immediately detected by the clinician. defect involves the use of the "change bed label" feature at the information center ix. if the configuration for this item is set to "optional" and a user selects the "location" button within the "manage patient" menu and makes a change to the patient location alarms for sp02 and/or non invasive blood pressure (nbp) will become disabled without visual notification (bell with an "x") to the user. this problem only happens when the patient is monitored using a networked intellivue trx telemetry m4841/trx4851a patient worn device (pwd).